HOME >> BIOLOGY >> NEWS
New drug boosts fight against HIV, researchers find

A new drug that advances the fight against HIV has been found to work better than treatments currently on the market, research led by a University of Toronto and Toronto General Hospital scientist has revealed.

"In most trials where HIV drugs go head to head, they usually end with one being as equally effective as the other. This is the first time that one protease inhibitor drug combination has been found to work better than another in patients who haven't received treatment before," says Dr. Sharon Walmsley, associate professor of medicine at U of T and senior scientist at Toronto General Hospital, University Health Network. Walmsley is lead author of a paper to appear in the June 27 issue of The New England Journal of Medicine. "The new drug combination is superior in inhibiting the virus and it's easier for patients to take. We also found that patients did not develop resistance to the drug, a major factor in HIV treatment."

The human immunodefficiency virus is a type of retrovirus that attacks the body's immune system. An enzyme called the protease enables the HIV virus to mature and replicate itself. One class of anti-retroviral drugs used to treat HIV is protease inhibitors, which work by blocking the protease thereby halting the replication process. They are typically used in combination with another class of anti-retroviral agents called reverse transcriptase inhibitors that hamper an earlier stage of HIV replication.

In the double-blind trial, the researchers tested 653 HIV-infected adults from 13 countries who had not previously received anti-retroviral therapy. Walmsley and her colleagues tested the new drug (a lopinavir-ritonavir combination, which is essentially two protease inhibitors in one) against nelfinavir (the most common protease inhibitor used in Canada). Both sets of patients also received two other anti-HIV agents generally taken with protease inhibitors.

At the end of the 24- and 48-week periods, more patient
'"/>

Contact: Janet Wong
jf.wong@utoronto.ca
416-978-5949
University of Toronto
26-Jun-2002


Page: 1 2 3

Related biology news :

1. Commercialization deal boosts hope for new sickle-cell drug
2. EC boosts European electron microscopy research
3. Bioreactor boosts chemical fermentation by 50 percent: study
4. New genomics tool boosts diabetes research
5. DHEA boosts growth rate of human neural stem cells
6. Marine scientists discover nutrient pollution boosts fungi, bacteria killing Caribbean reefs
7. Sleep boosts ability to learn language, University of Chicago researchers find
8. $13 million grant boosts breast cancer research
9. New national studies show combined hormone replacement therapy boosts stroke, dementia
10. Green tea boosts antimicrobial properties of toothpaste
11. Study boosts confidence in potential screening tool for Alzheimers disease

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/14/2019)... ... January 14, 2019 , ... CellMax Life , a ... blood, will present new findings at the ASCO Gastrointestinal Cancer Symposium in San ... results from this study show CellMax Life’s blood test, based on its proprietary ...
(Date:1/10/2019)... ... 2019 , ... Dr. Beanlands is the Vered Chair and Division Head of ... is also Director of its National Cardiac PET Centre, and Professor in the University's ... in the Department of Cellular and Molecular medicine. , He is a founding member ...
(Date:1/10/2019)... ... January 10, 2019 , ... A major goal for ... vitro studies and significantly more expensive in vivo studies in order to reduce ... address this need, researchers have begun to adopt 3D cell culture models which ...
Breaking Biology News(10 mins):
(Date:1/30/2019)... ... January 29, 2019 , ... Actus Therapeutics, a ... of the first patient in a phase 1/2 clinical study of ACTUS-101 in ... high morbidity and often leads to premature death. There are variable rates ...
(Date:1/30/2019)... VERONA, Italy (PRWEB) , ... January 30, 2019 ... ... Without Walls section of the international tasting 5StarWines to promote and give recognition ... sulfite wines. The Wine Without Walls selection takes place in Verona, Italy, contemporaneously ...
(Date:1/24/2019)... ... January 23, 2019 , ... ... has awarded microbiome research support in study design, planning, sample collection, and analysis ... Sciences, St. Augustine Campus in Trinidad led by Dr. Elaine Monica Davis, MBBS, ...
(Date:1/20/2019)... ... January 17, 2019 , ... Today, Advanced Solutions, ... of a specialized automation technology, titled Automate 3D. Automate 3D, produced by Advanced ... and drawings to deliver to end-users, customers, and ERP systems. , ...
Breaking Biology Technology:
Cached News: